A study comparing the safety and effectiveness of Infuse Bone Graft material to autogenous bone graft when used in maxillary sinus floor augmentation demonstrated that Infuse has similar rates of ...

MINNEAPOLIS (AP) -- Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft. The world's largest medical device ...

For the first time, U.S. regulators have cleared Medtronic's controversial Infuse Bone Graft biologic product for lower-back surgery for use with plastic — rather than titanium — spinal components.

In response to their prior inquiries, Medtronic Spine President Douglas King wrote letters to Minnesota Senators Al Franken and Amy Klobuchar, stating the adverse events that occurred during a study ...

Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...

(Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe.

Minneapolis-based Medtronic faces approximately 700 lawsuits involving 1,000 patients claiming personal injury due to the company’s Infuse bone graft product, according to the company’s SEC filing for ...

In a short news release issued Wednesday afternoon, Medtronic (NYSE:MDT) disclosed that the U.S. Department of Justice has closed its civil and criminal investigation into the company’s former ...

WASHINGTON, Nov 8 (Reuters) - Medtronic Inc's Infuse bone protein is a safe and effective treatment for use in facial and dental bone grafting procedures, the company told U.S. Food and Drug ...

In an unusual tactic, The Spine Journal has dedicated its June issue to a series of papers that carefully reject previous research supporting the use of Infuse, a controversial, but popular bone ...

MINNEAPOLIS (AP) — Medtronic says federal prosecutors have closed their investigation of the Minneapolis-based company’s InFuse bone graft. The medical device maker was being investigated by the U.S.